Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
Stopped early
Conditions studied: Relapsing Remitting Multiple Sclerosis
In brief
The investigators' overall hypothesis is that appearance or worsening of relapsing-remitting multiple sclerosis (RR-MS) symptoms are affected by various factors including stress, hormonal cycles, illness and missed medications.
Key facts
- Study ID
- NCT00919217
- Run by
- University of Louisville
- People needed
- 80
- Starts
- 2008-08-01
- Expected to finish
- 2025-05-01
- Last updated by the study team
- 2026-04-15
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- females
- diagnosed with relapsing-remitting multiple sclerosis
You may not qualify if…
- male
- no diagnosis of relapsing-remitting MS
- diagnosis of any other autoimmune disease or fibromyalgia
- peri-, post-, or surgically menopausal
- pregnant within past year or nursing
- history of chemotherapy
- on experimental medications
- treatment with steroids in the last 30 days
Where it is running
- University of Louisville (recruiting nationwide) — Louisville, Kentucky, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.